SCHEMBL3201581

SCHEMBL3201581

CN(O)C(=O)OCc1ccccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.49
MAPT P10636 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CASP3 P42574 3/20 0.48
SENP8 Q96LD8 3/20 0.48
SENP7 Q9BQF6 3/20 0.48
SENP6 Q9GZR1 3/20 0.48
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP12 P39900 1/20 0.48
MAOB P27338 2/20 0.48
MAOA P21397 1/20 0.48
NPC1 O15118 2/20 0.47
ALDH1A1 P00352 1/20 0.46
HTT P42858 1/20 0.46
IDO1 P14902 2/20 0.46
NR4A2 P43354 2/20 0.45
PKM P14618 2/20 0.45
KMT2A Q03164 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6861382 0.82 MAPT (0.49) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL3195605 0.81 RAB9A (0.48) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL3195600 0.79 L3MBTL1 (0.46) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL2659085 0.79 RAB9A (0.57) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL984297 0.78 L3MBTL1 (0.57) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL9815841 0.78 L3MBTL1 (0.57) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL11027172 0.78 CASP3 (0.43) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL12617736 0.77 NPC1 (0.60) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL11581518 0.77 L3MBTL1 (0.55) RAB9AMAPTL3MBTL1CASP3SENP8
SCHEMBL4374949 0.77 L3MBTL1 (0.59) RAB9AMAPTL3MBTL1CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745377-B2 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation THE SCRIPPS RESEARCH INSTITUTE (US) 2010-06-29 US disclosed
US-7745377-B2 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation THE SCRIPPS RESEARCH INSTITUTE (US) 2010-06-29 US disclosed
US-7662644-B2 Use of specified fluorescent dyes to conjugate to antibody; detecting binding of an antibody to an antigen; antibody conjugate THE SCRIPPS RESEARCH INSTITUTE (US) 2010-02-16 US disclosed
US-7351797-B1 Labeled peptides, and processes and intermediates useful for their preparation THE SCRIPPS RESEARCH INSTITUTE (US) 2008-04-01 US disclosed
US-7351797-B1 Labeled peptides, and processes and intermediates useful for their preparation THE SCRIPPS RESEARCH INSTITUTE (US) 2008-04-01 US disclosed
US-20070218502-A1 LABELED PEPTIDES, PROTEINS AND ANTIBODIES AND PROCESSES AND INTERMEDIATES USEFUL FOR THEIR PREPARATION THE SCRIPPS RESEARCH INSTITUTE 2007-09-20 US disclosed
US-7176037-B2 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation THE SCRIPPS RESEARCH INSTITUTE (US) 2007-02-13 US disclosed
US-7176037-B2 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation THE SCRIPPS RESEARCH INSTITUTE (US) 2007-02-13 US disclosed
US-20050287518-A1 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation THE SCRIPPS RESEARCH INSTITUTE 2005-12-29 US disclosed
US-6951947-B2 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation THE SCRIPPS RESEARCH INSTITUTE (US) 2005-10-04 US disclosed
EP-1330471-A4 LABELED PEPTIDES, AND PROCESSES AND INTERMEDIATES USEFUL FOR THEIR PREPARATION SCRIPPS RESEARCH INST (US) 2005-03-30 EP disclosed
US-20040067537-A1 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation HAHN KLAUS M (US) 2004-04-08 US disclosed
EP-1330471-A1 LABELED PEPTIDES, AND PROCESSES AND INTERMEDIATES USEFUL FOR THEIR PREPARATION THE SCRIPPS RESEARCH INSTITUTE (US) 2003-07-30 EP disclosed
EP-1301473-A2 LABELED PEPTIDES, PROTEINS AND ANTIBODIES AND PROCESSES AND INTERMEDIATES USEFUL FOR THEIR PREPARATION The Scripps Research Institute (US) 2003-04-16 EP disclosed
US-20020055133-A1 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation SCRIPPS RESEARCH INSTITUTE, THE 2002-05-09 US disclosed
WO-2002028890-A1 LABELED PEPTIDES, AND PROCESSES AND INTERMEDIATES USEFUL FOR THEIR PREPARATION THE SCRIPPS RESEARCH INSTITUTE (US) 2002-04-11 WO disclosed
WO-2002008245-A2 LABELED PEPTIDES, PROTEINS AND ANTIBODIES AND PROCESSES AND INTERMEDIATES USEFUL FOR THEIR PREPARATION THE SCRIPPS RESEARCH INSTITUTE (US) 2002-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020055133-A1 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation ARHGEF1, RHOC, CIT RAB9A 185/4885MAPT 3198/4885L3MBTL1 2220/4885
US-20040067537-A1 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation CIT, RHOC, ARHGEF1 RAB9A 228/4885MAPT 3165/4885L3MBTL1 2278/4885
US-20070218502-A1 LABELED PEPTIDES, PROTEINS AND ANTIBODIES AND PROCESSES AND INTERMEDIATES USEFUL FOR THEIR PREPARATION CIT, RHOC, ARHGEF1 RAB9A 228/4885MAPT 3165/4885L3MBTL1 2278/4885
US-20050287518-A1 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation ARHGEF1, RHOC, CIT RAB9A 185/4885MAPT 3198/4885L3MBTL1 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.